Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Nabi Biopharmaceuticals · Rockville, MD United States ·(NASDAQ (GM): NABI)

Company Description

12276 Wilkins Ave.
Rockville, MD
20852
United States (Map)
Phone: 301-770-3099
Fax: 301-770-3097
Toll Free: 800-685-5579
    View Nabi Biopharmaceuticals Locations On A US MapThis link will open in a new window
    Nabi Biopharmaceuticals nabs human antibodies to make pharmaceutical therapies. The biotechnology company makes vaccine products for diseases in a number of areas, including infectious diseases and nicotine addiction. Its vaccine for nicotine addition, NicVAX, works by stimulating antibodies that reduce cravings. It had been developing StaphVax, an investigational vaccine designed to fight certain hospital-acquired infections, until it failed certain trials. The company modified the drug and renamed it PentaStaph. Nabi had marketed one product, hepatitis B vaccine Nabi-HB; but it sold Nabi-HB along with some other assets in 2007 in order to focus on its other development programs. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Nabi Biopharmaceuticals Financials

    Company TypePublic - NASDAQ (GM): NABI

    Headquarters
    Fiscal Year-EndDecember
    2008 Sales (mil.)$0.0
    2008 Employees40

    Nabi Biopharmaceuticals Executives

    15 executives listed for Nabi Biopharmaceuticals's Rockville, MD location.
    TitleName & BioContact
    ChairmanGeoffrey CoxNetwork
    President, CEO, Acting CFO, and DirectorRaafat FahimNetwork
    SVP Strategic Planning and Business OperationsMatthew KalnikNetwork

    Competition

    Competitive Landscape for Nabi Biopharmaceuticals
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top Nabi Biopharmaceuticals Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!